ArQule Presents Results From Phase 1b Expansion Study of ARQ 092 at the 2015 European Cancer Conference
September 28, 2015 at 07:33 AM EDT
ArQule, Inc. (NASDAQ: ARQL) today announced preliminary results for the ongoing phase 1b expansion study in oncology for ARQ 092, an ...